Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Posterior Capsule Opacification

Posterior Capsule Opacification

📧 Sign up to get email alerts when something new happens for Posterior Capsule Opacification.

Top drugs studied for this disease

MICS IOL L313 (1)
Brinzolamide/brimonidine combination (1)
Hydrophobic Acrylic Intraocular Lens (study device) (1)
Silicone 3-piece intraocular lens (1)
Hydrophobic acrylic 3-piece intraocular lens (1)
Tecnis ZCB00 (1)
AcrySof SA60AT (1)
AcrySof IOL (single-piece intraocular lens) (1)
Brimonidine 0.2% (1)
Hoya iMics NY-60 (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms